All Type of News
U.S. FDA designates Hanmi Pharm’s LAPSGlucagon Analog as orphan drug
LAPSGlucagon Analog(HM15136) that Hanmi Pharm is developing as a congenital hyperinsulinemia treatment has been recognized as an orphan drug from the U.S. FDA on the 1st.
The Orphan Drug Designation program by the FD...
Yuhan Corporation acquires approval of clinical trial for cancer immunotherapy for first time in KoreaImmuneOncia(CEO Kwang-Ho Jung), a subsidiary of Yuhan Corporation, announced that the company has acquired approval of the Phase I clinical trial plan for IMC-011, a cancer immu...
|
KSHP requests for including pharmacists in the group of people designated for patient safety
The Korean Society of Health-system Pharmacists(President Eun-Sook Lee, KSHP) has strongly requested for revision to the Patient Safety Act so that pharmacists could be included in the group of people designated for p...
MFDS plans to approve 3 medicines developed in Korea through support for commercialization
The Ministry of Food and Drug Safety(MFDS) announced a plan to generate more than 3 new drugs developed in Korea by revising the medical approval system and supporting Korean pharmaceutical companies to commercialize ...
Series of hepatitis B treatments enter Seoul National University Hospital, warning fierce competition
As Ildong Pharmaceutical’s ‘Besivo’ entered Seoul National University Hospital January after Gilead Sciences’ ‘Vemlidy’ last December, it has notified even fiercer competition in the chronic type B hepatitis market. T...
GC Pharma’s ‘Perami Flu’ increases quadrupleAlong with the global record-breaking cold wave and flu(influenza), an injection-type flu treatment has attracted people as a new treatment option.
GC Pharma(CEO Eun-Cheol Huh)...
|
Ildong Pharmaceutical’s Aronamin grows significantly with more than KRW 70 billion salesIldong Pharmaceutical’s Aronamin has taken a strong upward trend. S
Ildong Pharmaceutical confirmed Aronamin made more than KRW 70 billion sales last year. In consideration of ...
|
Operating ‘Combined 6-Year’ and ‘2+4 Year’ for College of Pharmacy
Will the 2+4 curriculum of college of pharmacy become a combined 6-year curriculum that the pharmacology field want? The Policy Advisory Committee for Reorganization of the College of Pharmacy System suggested combina...
Total 15 products generated since Sewon Cellontech’ Chondron’s first approvalEven since Sewon Cellontech’s cartilage cell ‘Chondron’ acquired approval as the firs stem cell treatment in 2001, total 15 products had acquired approval as stem cell therapy u...
|
Will the survey of highly consumed OTC drugs stay remained?
While the people have constantly criticized necessity of price investigation on highly-consumed OTC drugs, the Ministry of Health and Welfare(MOHW) has had more concerns since the investigation got terminated last yea...
